查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1881541

全球配製藥房市場－產業規模、佔有率、趨勢、機會及預測，依治療領域、給藥途徑、最終用戶、地區及競爭格局分類，2020-2030年預測

Compounding Pharmacy Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Therapeutic Area, By Route of Administration, By End User By Region and Competition, 2020-2030F
出版日期: | 出版商: TechSci Research | 英文 183 Pages | 商品交期: 2-3個工作天內

價格

We offer 8 hour analyst time for an additional research. Please contact us for the details.

簡介目錄

2024年全球配製藥房市場規模為129.8億美元，預計到2030年將以6.52%的複合年成長率成長至189.6億美元。全球配製藥房市場涵蓋藥劑師為個別患者定製藥物的專業實踐，旨在滿足大規模生產的藥品無法滿足的獨特治療需求。這種客製化可能涉及特定劑型、去除過敏原或改善適口性。

市場概覽
預測期 2026-2030
2024年市場規模 129.8億美元
2030年市場規模 189.6億美元
2025-2030年複合年成長率 6.52%
成長最快的細分市場 疼痛管理
最大的市場 北美洲

主要市場促進因素

主要市場挑戰

主要市場趨勢

目錄

第1章：產品概述

第2章：研究方法

第3章：執行概要

第4章：客戶之聲

第5章：全球配製藥房市場展望

  • 市場規模及預測
    • 按價值
  • 市佔率及預測
    • 依治療領域分類（疼痛管理、荷爾蒙替代療法、皮膚疾病、營養補充品、其他治療領域）
    • 依給藥途徑（口服、外用、注射、其他給藥途徑）
    • 依最終用戶（人類、獸醫）分類
    • 按地區
    • 按公司（2024 年）
  • 市場地圖

第6章：北美複方藥局市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 北美洲：國家分析
    • 美國
    • 加拿大
    • 墨西哥

第7章：歐洲複方藥局市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 歐洲：國家分析
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙

第8章：亞太地區複方藥局市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 亞太地區：國家分析
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲

第9章：中東和非洲複方藥局市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 中東和非洲：國家分析
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 南非

第10章：南美洲複方藥局市場展望

  • 市場規模及預測
  • 市佔率及預測
  • 南美洲：國家分析
    • 巴西
    • 哥倫比亞
    • 阿根廷

第11章：市場動態

  • 促進要素
  • 挑戰

第12章：市場趨勢與發展

  • 併購（如有）
  • 產品發布（如有）
  • 最新進展

第13章：全球配製藥房市場：SWOT分析

第14章：波特五力分析

  • 產業競爭
  • 新進入者的潛力
  • 供應商議價能力
  • 顧客的力量
  • 替代產品的威脅

第15章：競爭格局

  • Wedgewood Pharmacy
  • B. Braun Medical Inc.
  • Fagron NV
  • Fresenius Kabi
  • Clinigen Group PLC
  • Dougherty's Pharmacy, Inc.
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • Institutional Pharmacy Solutions
  • Mcguff compounding pharmacy services

第16章：策略建議

第17章調查會社について,免責事項

簡介目錄
Product Code: 21428

The Global Compounding Pharmacy Market, valued at USD 12.98 Billion in 2024, is projected to experience a CAGR of 6.52% to reach USD 18.96 Billion by 2030. The global compounding pharmacy market encompasses the specialized practice of pharmacists creating tailored medications for individual patients, addressing unique therapeutic requirements that are not fulfilled by mass-produced pharmaceuticals. This customization may involve specific dosage forms, allergen removal, or enhanced palatability.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 12.98 Billion
Market Size 2030USD 18.96 Billion
CAGR 2025-20306.52%
Fastest Growing SegmentPain Management
Largest MarketNorth America

Key Market Drivers

The increasing demand for personalized medication is a primary catalyst for the Global Compounding Pharmacy Market. Patients frequently require pharmaceutical formulations precisely adjusted for specific allergies, unique dosage strengths, or alternative administration routes not commercially available. This customization is crucial for optimizing therapeutic outcomes and minimizing adverse reactions, driving demand for tailored solutions. According to the Alliance for Pharmacy Compounding, in their "2023-2024 Compounding Pharmacy Snapshot" published in July 2024, in the median hybrid pharmacy, 3% of all prescriptions were for compounded medications, demonstrating significant reliance on individualized preparations.

Key Market Challenges

The stringent and evolving regulatory environment presents a significant challenge to the global compounding pharmacy market. Varying jurisdictional oversight and complex compliance requirements for quality assurance and safety impose considerable operational complexities and financial burdens on compounding pharmacies. These escalating demands directly impede market expansion by increasing operating costs and diverting resources from potential growth initiatives. For instance, according to the Alliance for Pharmacy Compounding, in Fall 2023, 15% of all surveyed compounding pharmacies ceased hazardous drug compounding due to compliance costs associated with new USP Chapter <800> standards.

Key Market Trends

Advanced Compounding Technology Integration is a key driver for market growth, emphasizing the adoption of automation, robotics, and sophisticated software within compounding pharmacies. This integration aims to enhance precision, reduce the potential for human error, and improve overall operational efficiency, which is crucial for handling complex formulations and increasing production volumes while adhering to stringent quality standards. This trend supports pharmacies in meeting the evolving demands for customized medications. According to the Alliance for Pharmacy Compounding's demographic survey in Fall 2023, 529 unique 503A compounding pharmacies or 503B outsourcing facilities were represented, underscoring the significant number of entities potentially benefiting from these technological advancements.

Key Market Players

  • Wedgewood Pharmacy
  • B. Braun Medical Inc.
  • Fagron NV
  • Fresenius Kabi
  • Clinigen Group PLC
  • Dougherty's Pharmacy, Inc.
  • Lorraine's Pharmacy
  • Rx3 Compounding Pharmacy
  • Institutional Pharmacy Solutions
  • Mcguff compounding pharmacy services

Report Scope:

In this report, the Global Compounding Pharmacy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Compounding Pharmacy Market, By Therapeutic Area:

  • Pain Management
  • Hormone Replacement
  • Dermal Disorders
  • Nutritional Supplements
  • Other Therapeutic Areas

Compounding Pharmacy Market, By Route of Administration:

  • Oral
  • Topical
  • Parenteral
  • Other Route of Administrations

Compounding Pharmacy Market, By End User:

  • Humans
  • Veterinary

Compounding Pharmacy Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Compounding Pharmacy Market.

Available Customizations:

Global Compounding Pharmacy Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Compounding Pharmacy Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Therapeutic Area (Pain Management, Hormone Replacement, Dermal Disorders, Nutritional Supplements, Other Therapeutic Areas)
    • 5.2.2. By Route of Administration (Oral, Topical, Parenteral, Other Route of Administrations)
    • 5.2.3. By End User (Humans, Veterinary)
    • 5.2.4. By Region
    • 5.2.5. By Company (2024)
  • 5.3. Market Map

6. North America Compounding Pharmacy Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Therapeutic Area
    • 6.2.2. By Route of Administration
    • 6.2.3. By End User
    • 6.2.4. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Compounding Pharmacy Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Therapeutic Area
        • 6.3.1.2.2. By Route of Administration
        • 6.3.1.2.3. By End User
    • 6.3.2. Canada Compounding Pharmacy Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Therapeutic Area
        • 6.3.2.2.2. By Route of Administration
        • 6.3.2.2.3. By End User
    • 6.3.3. Mexico Compounding Pharmacy Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Therapeutic Area
        • 6.3.3.2.2. By Route of Administration
        • 6.3.3.2.3. By End User

7. Europe Compounding Pharmacy Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Therapeutic Area
    • 7.2.2. By Route of Administration
    • 7.2.3. By End User
    • 7.2.4. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. Germany Compounding Pharmacy Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Therapeutic Area
        • 7.3.1.2.2. By Route of Administration
        • 7.3.1.2.3. By End User
    • 7.3.2. France Compounding Pharmacy Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Therapeutic Area
        • 7.3.2.2.2. By Route of Administration
        • 7.3.2.2.3. By End User
    • 7.3.3. United Kingdom Compounding Pharmacy Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Therapeutic Area
        • 7.3.3.2.2. By Route of Administration
        • 7.3.3.2.3. By End User
    • 7.3.4. Italy Compounding Pharmacy Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Therapeutic Area
        • 7.3.4.2.2. By Route of Administration
        • 7.3.4.2.3. By End User
    • 7.3.5. Spain Compounding Pharmacy Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Therapeutic Area
        • 7.3.5.2.2. By Route of Administration
        • 7.3.5.2.3. By End User

8. Asia Pacific Compounding Pharmacy Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Therapeutic Area
    • 8.2.2. By Route of Administration
    • 8.2.3. By End User
    • 8.2.4. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Compounding Pharmacy Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Therapeutic Area
        • 8.3.1.2.2. By Route of Administration
        • 8.3.1.2.3. By End User
    • 8.3.2. India Compounding Pharmacy Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Therapeutic Area
        • 8.3.2.2.2. By Route of Administration
        • 8.3.2.2.3. By End User
    • 8.3.3. Japan Compounding Pharmacy Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Therapeutic Area
        • 8.3.3.2.2. By Route of Administration
        • 8.3.3.2.3. By End User
    • 8.3.4. South Korea Compounding Pharmacy Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Therapeutic Area
        • 8.3.4.2.2. By Route of Administration
        • 8.3.4.2.3. By End User
    • 8.3.5. Australia Compounding Pharmacy Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Therapeutic Area
        • 8.3.5.2.2. By Route of Administration
        • 8.3.5.2.3. By End User

9. Middle East & Africa Compounding Pharmacy Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Therapeutic Area
    • 9.2.2. By Route of Administration
    • 9.2.3. By End User
    • 9.2.4. By Country
  • 9.3. Middle East & Africa: Country Analysis
    • 9.3.1. Saudi Arabia Compounding Pharmacy Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Therapeutic Area
        • 9.3.1.2.2. By Route of Administration
        • 9.3.1.2.3. By End User
    • 9.3.2. UAE Compounding Pharmacy Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Therapeutic Area
        • 9.3.2.2.2. By Route of Administration
        • 9.3.2.2.3. By End User
    • 9.3.3. South Africa Compounding Pharmacy Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Therapeutic Area
        • 9.3.3.2.2. By Route of Administration
        • 9.3.3.2.3. By End User

10. South America Compounding Pharmacy Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Therapeutic Area
    • 10.2.2. By Route of Administration
    • 10.2.3. By End User
    • 10.2.4. By Country
  • 10.3. South America: Country Analysis
    • 10.3.1. Brazil Compounding Pharmacy Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Therapeutic Area
        • 10.3.1.2.2. By Route of Administration
        • 10.3.1.2.3. By End User
    • 10.3.2. Colombia Compounding Pharmacy Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Therapeutic Area
        • 10.3.2.2.2. By Route of Administration
        • 10.3.2.2.3. By End User
    • 10.3.3. Argentina Compounding Pharmacy Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Therapeutic Area
        • 10.3.3.2.2. By Route of Administration
        • 10.3.3.2.3. By End User

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Compounding Pharmacy Market: SWOT Analysis

14. Porter's Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Wedgewood Pharmacy
    • 15.1.1. Business Overview
    • 15.1.2. Products & Services
    • 15.1.3. Recent Developments
    • 15.1.4. Key Personnel
    • 15.1.5. SWOT Analysis
  • 15.2. B. Braun Medical Inc.
  • 15.3. Fagron NV
  • 15.4. Fresenius Kabi
  • 15.5. Clinigen Group PLC
  • 15.6. Dougherty's Pharmacy, Inc.
  • 15.7. Lorraine's Pharmacy
  • 15.8. Rx3 Compounding Pharmacy
  • 15.9. Institutional Pharmacy Solutions
  • 15.10. Mcguff compounding pharmacy services

16. Strategic Recommendations

17. About Us & Disclaimer